FDA NDC Directory · JSON-LD · Markdown

SPEVIGO

NDC 50222-362 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namespesolimab
Labeler / ManufacturerLEO Pharma Inc.
Marketing categoryBiologic License Application · App BLA761244
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsSPESOLIMAB (300 mg/2mL)
Marketing started20260309
Package count2

External sources

Source: openFDA. Public-domain (CC0).